Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 15 results found. Search for [ cipla stock analysis ]

Results 1 to 15 of 15
BusinessToday.In
May 15, 2020
Cipla's net profit during the March quarter of FY20 took a beating on account of the coronavirus pandemic. The company posted a 33 per cent decline in consolidated net profit during the quarter ended March 2020


BusinessToday.In
May 1, 2020
Corona lockdown extension live updates: Centre extends coronavirus lockdown till May 17; Home Ministry issues guidelines for restrictions and relaxations in different zones across India


PB Jayakumar
New Delhi, April 15, 2020
How healthcare, FMCG, pharma, petrochemical and IT companies will turn the capabilities acquired during the coronavirus crisis into new businesses in India and abroad


BusinessToday.In
January 15, 2020
Share Market Update: IndusInd Bank, Tata Steel, UltraTech Cement, SBI, Infosys, Axis Bank and ICICI Bank were the among the top losers. On the other hand, Titan, Hero MotoCorp, Tech Mahindra, Nestle and Sun Pharma were the top gainers.


PTI
New Delhi, August 7, 2016
In a sharp jump, average CEO salary at top listed companies in the private sector is approaching Rs 20 crore -- double the level seen just two years ago at about Rs 10 crore.


PTI
New Delhi, February 22, 2016
The holding of Life Insurance Corporation (LIC) declined in five other blue-chips in the third quarter from the level seen in the preceding three months, showed an analysis of the shareholding pattern of the Sensex constituents.


BT Online
New Delhi, October 12, 2015
The net sales and profits of listed Indian corporates may fall on the year-on-year basis in Q2FY16, analysts said, indicating the road ahead may still be wobbly for economic recovery and stock market.


PTI
New Delhi, May 18, 2015
The insurance major has picked maximum stake in Coal India during the quarter under review - 4.65 per cent stake worth Rs 10,754 crore in Coal India.


E Kumar Sharma
April 1, 2013
The Supeme Court has refused protection for Novartis' blood cancer drug Glivec on the grounds that it is not a new medicine but only an amended version of a known compound.


Sarbajeet K. Sen, Rahul Oberoi and Sowmya Kamath
Delhi, November 17, 2011
While the top guns of India's stock markets have made widely different bets for the future, there's a common thread that runs through their strategies. All of them are hopeful about the growth of India's equity market and its ability to create wealth over the long run.


Rahul Oberoi/Money Today
Delhi, October 5, 2011
We bring you six index heavyweight stocks that are capable of delivering steady returns in the long run.


Suman Layak
October 9, 2010
Most of the CEOs of India's top 30 companies that constitute the benchmark index on the Bombay Stock Exchange do not boast of MBA degrees.


Hemen Kapadia
May 24, 2010
The Nifty's slide is no reason to worry. In fact, it's time to scout for stocks that are bound to yield good returns in the medium term.


Virendra Verma
November 13, 2008
After years of rollicking appreciation, companies that make up the BT 500 are going through one of their toughest phases in a long, long time. As stocks get mercilessly hammered, this may just be the time when the men are separated from the boys. Virendra Verma reports.


By Mahesh Nayak
August 31, 2007
With new industries and businesses taking off, the war for top management talent has pushed CEO salaries to record levels. But the fact is, not every CEO is getting paid obscenely and certainly not as much as what some CEOs in the US take home.


PAGES 1 OF 1